-
There's Uncertainty Around Apple's Patent Appeal For Watch, Masimo's Royalty Exposure Is Priced In - Analyst Downgrades
Wednesday, January 3, 2024 - 2:30pm | 338Needham downgraded Masimo Corporation (NASDAQ: MASI), noting that though Apple Inc (NASDAQ: AAPL) royalties are not certain, but are mostly priced into MASI shares. Wednesday, a U.S. appeals court temporarily halted the government commission's import ban on certain...
-
Exceeding Expectations: McKesson Achieves Strong Performance and Rewards Investors
Tuesday, January 2, 2024 - 11:05am | 881On January 02, 2024, McKesson (NYSE:MCK) will distribute a dividend payout of $0.62 per share, equating to an annualized dividend yield of 0.55%. Shareholders who owned the stock before the ex-dividend date on November 30, 2023 will receive this payout. McKesson Recent Dividend Payouts...
-
Luna's Lunar Leap: Grabs $50M Investment To Fuel Silixa Buyout & More
Thursday, December 21, 2023 - 1:40pm | 379Luna Innovations Inc (NASDAQ: LUNA) disclosed a strategic investment of $50 million from White Hat Capital Partners. The company will partially use the proceeds to fund the acquisition of Silixa, which was announced today, for $21.5 million in upfront cash consideration and up to an...
-
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
Thursday, December 21, 2023 - 9:54am | 523The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. Tarpeyo was first approved in...
-
Monogram Orthopedics' Surgical Robot Now Reality As Company Delivers First System
Thursday, December 7, 2023 - 9:15am | 965Robotic surgeries are going mainstream for a good reason: they make it easier for doctors to perform complex surgeries. Monogram Orthopedics Inc. (NASDAQ: MGRM), which aims to revolutionize orthopedic joint replacement surgery with its robotic technology, just got one step closer to achieving that...
-
Zoom Video, Agilent And 3 Stocks To Watch Heading Into Monday
Monday, November 20, 2023 - 6:44am | 325With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Agilent Technologies, Inc. (NYSE: A) to report quarterly earnings at $1.35 per share on revenue of $1.67 billion after the closing bell. Agilent...
-
Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
Monday, November 13, 2023 - 1:18pm | 302Moleculin Biotech Inc (NASDAQ: MBRX) provided a preliminary update on recent clinical activity from annamycin lead development programs. Annamycin is the company's next-generation anthracycline that has been designed to be non-cardiotoxic (unlike currently prescribed anthracyclines)...
-
Why Is Neurocrine Biosciences Stock Trading Lower Today?
Friday, November 10, 2023 - 2:43pm | 380Thursday, Neurocrine Biosciences Inc (NASDAQ: NBIX) released Phase 2 study results from two signal-seeking pipeline programs in focal onset seizures and anhedonia. The investigational selective NaV 1.6 inhibitor, NBI-921352, licensed from Xenon Pharmaceuticals Inc (...
-
Masimo Might See Potential Royalty Windfall From ITC's Exclusion Order On Apple Watch: Analyst
Friday, October 27, 2023 - 2:44pm | 523Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI) with a price target of $136. On Thursday, the ITC upheld a January judge's decision in an exclusion order, which found Apple Inc. (NASDAQ: AAPL) guilty of infringing...
-
Bankrupt Rite Aid, McKesson Strike Deal To Secure Steady Drug Deliveries
Wednesday, October 18, 2023 - 8:41am | 382Rite Aid Corporation (NYSE: RAD) and drug supplier McKesson Corp (NYSE: MCK) have reached a settlement, securing the continued fulfillment of customer prescriptions throughout Rite Aid's ongoing bankruptcy proceedings. The lawsuit against McKesson alleged that the...
-
Why Fortrea Holdings Shares Are Gaining Today
Tuesday, October 17, 2023 - 9:23am | 439Activist hedge fund Starboard Value holds a stake of around 8.7% in contract-research organization Fortrea Holdings Inc. (NASDAQ: FTRE), according to an exchange filing. The activist investor plans to push for changes that could boost margins among other initiatives...
-
Wolfspeed's Future Relies On Mohawk Valley Fab: Analyst
Thursday, October 12, 2023 - 3:15pm | 461Piper Sandler analyst Harsh V. Kumar reiterated the Overweight rating on Wolfspeed, Inc. (NYSE: WOLF), lowering the price target to $55 from $75. The company will publish its Q1 results on Monday, October 30, 2023. Given the sale of the RF business to MACOM Technology...
-
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
Wednesday, October 11, 2023 - 2:27pm | 463Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are in development, none are approved by regulators or insurance reimbursement. Some...
-
Why Is Neurocrine Biosciences Shares Trading Higher Today?
Thursday, October 5, 2023 - 2:38pm | 252Neurocrine Biosciences Inc (NASDAQ: NBIX) released topline data from the Phase 3 CAHtalyst Pediatric Study of crinecerfont in children and adolescents with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. CAH is an inherited condition that affects...
-
Ligand Pharma Updates Annual Guidance As It Spins Out Pelican Subsidiary
Tuesday, September 19, 2023 - 1:15pm | 344Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) entered into a merger agreement under which its subsidiary, Pelican Technology Holdings Inc, has become a wholly owned subsidiary of Primrose Bio Inc. Primrose Bio is a stand-alone private company focused on synthetic biology....